tjo-087
Showing 1 - 1 of 1
Dry Eye Syndrome Trial in Seoul (TJO-087, Cyclosporine ophthalmic solution 0.05%)
Recruiting
- Dry Eye Syndrome
- TJO-087
- Cyclosporine ophthalmic solution 0.05%
-
Seoul, Korea, Republic ofHyo Myung, Kim
Feb 8, 2022